Profil
Andrew James McLean is currently a Non-Executive Director at Vaccitech (UK) Ltd. and a Director at Theolytics Ltd. He was previously a Director at Argonaut Therapeutics Ltd. and a Director at Osler Diagnostics Ltd. from 2016 to 2019.
Postes actifs de Andrew James McLean
| Sociétés | Poste | Début |
|---|---|---|
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Directeur/Membre du Conseil | - |
Theolytics Ltd.
Theolytics Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Directeur/Membre du Conseil | - |
Anciens postes connus de Andrew James McLean
| Sociétés | Poste | Fin |
|---|---|---|
Osler Diagnostics Ltd.
Osler Diagnostics Ltd. BiotechnologyHealth Technology Engages in research and development in biotechnology | Directeur/Membre du Conseil | 31/12/2019 |
Argonaut Therapeutics Ltd.
Argonaut Therapeutics Ltd. BiotechnologyHealth Technology Develops epigenetically-acting drugs which target abnormal arginine methylation in cancer | Directeur/Membre du Conseil | 09/10/2019 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Theolytics Ltd.
Theolytics Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Argonaut Therapeutics Ltd.
Argonaut Therapeutics Ltd. BiotechnologyHealth Technology Develops epigenetically-acting drugs which target abnormal arginine methylation in cancer | Health Technology |
Osler Diagnostics Ltd.
Osler Diagnostics Ltd. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
















